Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q4 FY2022 Earnings Presentation
21 slides from Rossari Biotech's earnings presentation, May 24, 2022
Slide 1: Covering letter: Revised Q4 FY22 Earnings Presentation
® ROSSARI making you more competitive May 24, 2022 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No.C/1, 'G'Block, Bandra- Kurla Complex Dalal Street, Fort Mumbai 400
Slide 2: Rossari Biotech Limited Q4 & FY22 Results Presentation
® ROSSARI making you mor,e comp,etitive Rossari Biotech Limited Q4 & FY22 Results Presentation May 19, 2022
Slide 3: Disclaimer
® Disclaimer ROSSARI making you more competitive Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticip
Slide 4: Q4 & FY22 Results Overview
ROSSARI making you more competi tive Q4 & FY22 Results Overview 3
Slide 5: Q4 FY22 – Key Financial Highlights
Q4 FY22 – Key Financial Highlights ® ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 24.1 52.3 428.4 438.9 47.9 22.8 22.2 36.0 218.2 Q3 FY22 Q4 FY21 Q4 FY22 Q3 FY22 Q4 FY21 Q4 FY22 Q3 FY22 Q4 FY21 Q4 FY22 Shift % (Y-o-Y) 101% 45% 8% Shift %
Slide 6: FY22 – Key Financial Highlights
FY22 – Key Financial Highlights ® ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 97.7 80.0 183.4 1482.9 124.0 709.3 FY21 FY22 FY21 FY22 FY21 FY22 Shift % (Y-o-Y) 109% 49% 22% Margins (%) 17.5% 12.5% 11.3% 6.6% Note: 1) All figures, unless m
Slide 7: Management Message
Management Message ROSSARI making you more competitive Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We are happy to share that we have closed the year on an encouraging note, despite m
Slide 8: Key Developments
Key Developments ® ROSSARI making you more competitive Successful conclusion of acquisition and integration of Unitop, Tristar, and Romakk Chemicals in FY2022 • All three companies have delivered encouraging performance during the year on the back of healthy demand and volume offtake in the markets
Slide 9: Key Developments
Key Developments ® ROSSARI making you more competitive Recent acquisitions augment Rossari’s innovation and technological capabilities • Integration of Unitop, Tristar, and Romakk Chemicals has notably enhanced Rossari’s technical capacity in two key chemistries, namely surfactants and silicones • P
Slide 10: Key Developments
Key Developments ® ROSSARI o In sync with its strategy to introduce Green Chemistries, Rossari’s R&D has successfully introduced green products in newer segments to reduce high TDS and save energy by designing products that work at lower temperatures. The state-of-the-art 'Sustainable dyeing’, progr
Slide 11: Key Developments
Key Developments Announces annual dividend of Re. 0.50/- per share • For FY 2021-22, the Board of Directors recommended a dividend of Re. 0.50 /- per share • For details on dividend distribution policy, please refer to the Company’s website at Rossari - Dividend Distribution Policy 10
Slide 12: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Y-o-Y Change Y-o-Y Change Particulars (Rs. crore) Q4 FY22 Q4 FY21 FY22 FY21 (%) (%) Revenues from Operations 438.9 218.2 101% 1,482.9 709.3 109% Total Expenditure • COGS 324.4 150.6 115% 1,105.0 462.2 139% • Employee benefits expense 22.2 11.6 91% 67.9 42 62% •
Slide 13: Consolidated Balance Sheet
Consolidated Balance Sheet EQUITY AND LIABILITIES CONSOLIDATED CONSOLIDATED ASSETS CONSOLIDATED CONSOLIDATED As on 31st March 2022 As on 31st March 2021 As on 31st March 2022 As on 31st March 2021 Particulars (Rs. crore) Particulars (Rs. crore) (Audited) (Audited) (Audited) (Audited) EQUITY ASSETS E
Slide 14: Consolidated Cash Flows
Consolidated Cash Flows CASH FLOW CONSOLIDATED CONSOLIDATED CASH FLOW CONSOLIDATED CONSOLIDATED As on 31st March As on 31st March As on 31st March 2022 As on 31st March 2021 Particulars (Rs. crore) Particulars (Rs. crore) 2022 (Audited) 2021 (Audited) (Audited) (Audited) Cash flows from operating ac
Slide 15: Q4 FY22 - Segment-wise Details
Q4 FY22 - Segment-wise Details Segment-wise Revenue Break-up (Rs. crore) Q4 FY21 Q3 FY22 Q4 FY22 294.0 303.6 108.5 110.6 109.8 87.9 21.8 23.8 25.5 HPPC TSC AHN Shift (Y-o-Y) % 180% 25% 17% Shift (Q-o-Q) % 3% -0.1% 7% Note: 1) All figures, unless mentioned otherwise, are on a consolidated basis 2) Ho
Slide 16: FY22 - Segment-wise Details
FY22 - Segment-wise Details Segment-wise Revenue Break-up (Rs. crore) FY21 FY22 966.1 399.4 404.7 251.6 112.1 58.3 HPPC TSC AHN Shift (Y-o-Y) % 142% 61% 54% Note: 1) All figures, unless mentioned otherwise, are on a consolidated basis 2) Home, Personal Care and Performance Chemicals (HPPC); Textile
Slide 17: Q4 FY22 - Financial and Operational Discussions (Y-o-Y)
Q4 FY22 - Financial and Operational Discussions (Y-o-Y) Net Revenues Q4 FY22 Revenues from operations stood at Rs. 438.9 crore, higher by 101% YoY; FY22 Revenues from operations up 109% YoY to Rs. 1,482.9 crore Steady demand and offtake resulted in healthy growth across all businesses during the q
Slide 18: Annexure
ROSSARI making you more competitive Annexure 17
Slide 19: Conference Call Details
Conference Call Details Q4 & FY22 Earnings Conference Call Time • 6:00 p.m. IST on Monday, May 23, 2022 To enable participants to connect to the conference call without Pre-registration having to wait for an operator, please register at the below mentioned link: Primary dial-in number • + 91 22 6280
Slide 20: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a For further information, please contact: Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Manasi Nisal Headquartered at Mumbai, India, the Company operates R
Slide 21: Thank you
® ROSSARI making you more competitive Thanky•u 20